- Full text PDF available (2)
Journals and Conferences
[This corrects the article on p. 33 in vol. 6, PMID: 27826421.].
The presence of a salvageable penumbra, a region of ischemic brain tissue with sufficient energy for short-term survival, has been widely agreed as the premise for thrombolytic therapy with tissue plasminogen activator (tPA), which remains the only United States Food and Drug Administration (FDA) approved treatment for acute ischemia stroke. However, the… (More)